Respiratory syncytial viral infection in infants with congenital heart disease
MacDonald N.E., Hall C.B., Suffin S.C., Alexson C., Harris P.J., Manning J.A. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982, 307:397-400.
Palivizumab in the prophylaxis of respiratory syncytial virus infection
Cardenas S., Auais A., Piedimonte G. Palivizumab in the prophylaxis of respiratory syncytial virus infection. Expert Rev Anti Infect Ther 2005, 3:719-726.
Development, implementation, and evaluation of a community- and hospital-based respiratory syncytial virus prophylaxis program
Bracht M., Heffer M., O'Brien K. Development, implementation, and evaluation of a community- and hospital-based respiratory syncytial virus prophylaxis program. Adv Neonatal Care 2005, 5:39-49.
Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units
Kurz H., Herbich K., Janata O., Sterniste W., Bauer K. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units. J Hosp Infect 2008, 70:246-252.
Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit
Halasa N.B., Williams J.V., Wilson G.J., Walsh W.F., Schaffner W., Wright P.F. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 2005, 24:1040-1044.
Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit
Abadesso C., Almeida H.I., Virella D., Carreiro M.H., Machado M.C. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J Hosp Infect 2004, 58:38-41.
The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit
Cox R.A., Rao P., Brandon-Cox C. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J Hosp Infect 2001, 48:186-192.
Comparison of the RSV respi-strip with direct fluorescent-antigen detection for diagnosis of respiratory syncytial virus infection in pediatric patients
Gregson D., Lloyd T., Buchan S., Church D. Comparison of the RSV respi-strip with direct fluorescent-antigen detection for diagnosis of respiratory syncytial virus infection in pediatric patients. J Clin Microbiol 2005, 43:5782-5783.
The clinical picture presented by premature neonates infected with the respiratory syncytial virus
Forster J., Schumacher R.F. The clinical picture presented by premature neonates infected with the respiratory syncytial virus. Eur J Pediatr 1995, 154:901-905.
Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit
Heerens A.T., Marshall D.D., Bose C.L. Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002, 22:306-307.